| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.74 |
| Other Income | ₹0.25 | ₹0.00 | ₹1.00 | ₹0.18 |
| Total Revenue | ₹0.25 | ₹0.00 | ₹1.00 | ₹0.92 |
| Total Expenses | ₹0.45 | ₹0.30 | ₹0.88 | ₹1.39 |
| Profit Before Tax | -₹0.21 | -₹0.30 | -₹4.23 | ₹0.67 |
| Tax | -₹0.07 | -₹0.03 | ₹0.00 | -₹0.05 |
| Profit After Tax | -₹0.13 | -₹0.27 | -₹4.23 | ₹0.72 |
| EPS - Basic | -₹0.21 | -₹0.46 | -₹7.24 | ₹1.23 |
| EPS - Diluted | -₹0.21 | -₹0.46 | -₹7.24 | ₹1.23 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹0.21 | -₹0.30 | -₹4.23 | ₹0.72 |
| Income before WC changes | -₹0.31 | -₹0.18 | ₹0.22 | -₹0.11 |
| Change in Assets | -₹0.01 | ₹0.00 | ₹0.40 | ₹1.75 |
| Change in Liabilities | -₹0.01 | ₹0.01 | -₹0.60 | -₹1.43 |
| Change in WC | -₹0.02 | ₹0.01 | -₹0.20 | ₹0.32 |
| Cash flow from Operations | -₹0.23 | -₹0.17 | ₹0.01 | ₹0.21 |
| Cash flow from Investing | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| Cash flow from Financing | ₹0.25 | ₹0.15 | ₹0.00 | -₹0.01 |
| Total Cash Flow | ₹0.02 | -₹0.02 | ₹0.01 | ₹0.20 |
| Cash (Start of the year) | ₹0.04 | ₹0.06 | ₹0.05 | -₹0.16 |
| Cash (End of the year) | ₹0.06 | ₹0.04 | ₹0.06 | ₹0.05 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹0.01 | ₹0.00 | ₹0.00 | ₹4.44 |
| Current Assets | ₹0.07 | ₹0.04 | ₹0.06 | ₹0.43 |
| Total Assets | ₹0.08 | ₹0.04 | ₹0.06 | ₹4.87 |
| Current Liabilities | ₹0.02 | ₹1.38 | ₹1.34 | ₹1.93 |
| Net Current Asset | ₹0.05 | -₹1.34 | -₹1.28 | -₹1.49 |
| Non-Current Liabilities | ₹1.55 | ₹0.03 | ₹0.29 | ₹0.30 |
| Equity Capital | -₹1.49 | -₹1.37 | -₹1.57 | ₹2.65 |
| Total Equity & Liabilities | ₹0.08 | ₹0.04 | ₹0.06 | ₹4.87 |
Adline Chem Lab Limited is an India-based company. The Company is engaged in the business of marketing pharmaceutical products. The Company operates in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. Its products for the international market include tablets, capsules and injections. Its veterinary products include B Complex Liver Extract with Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. It also offers educational supplements. It offers manufacturing facilities for tablets, capsules, liquid orals and small volume parentals for contract manufacturing.
ADLINE CHEM LAB LIMITED share price is ₹13.70 as on 22 May, 2026, 09:48 IST.
The Mutual Fund Shareholding in ADLINE CHEM LAB LIMITED was 0.00% at the end of Mar 2026.
The 52-week high and low of ADLINE CHEM LAB LIMITED share is ₹18.10 and ₹7.60 as of 22 May, 2026.
The market capitalisation of ADLINE CHEM LAB LIMITED is ₹8.01 Crores as on 22 May, 2026.
The stock symbol of ADLINE CHEM LAB LIMITED is 524604 on the BSE, and the ISIN is INE276T01018.
To buy ADLINE CHEM LAB LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
ADLINE CHEM LAB LIMITED shares closed yesterday at ₹13.70 on BSE
No, shares of ADLINE CHEM LAB LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ADLINE CHEM LAB LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.